M D Yahr, R C Duvoisin. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Amantadine/therapeutic useAmitriptyline/therapeutic useAmphetamine/therapeutic useAntiparkinson Agents/therapeutic useDihydroxyphenylalanine/administration & dosageDihydroxyphenylalanine/adverse effectsDihydroxyphenylalanine/therapeutic useDrug AntagonismDrug SynergismHumansImipramine/therapeutic useMethyldopa/therapeutic useMonoamine Oxidase Inhibitors/therapeutic useParasympatholytics/therapeutic useParkinson Disease/drug therapyPhenothiazines/therapeutic use
Substances: See more » Antiparkinson AgentsMonoamine Oxidase InhibitorsParasympatholyticsPhenothiazinesAmitriptylineMethyldopaDihydroxyphenylalanineAmantadineAmphetamineImipramine
Year: 1972 PMID: 4555145 DOI: 10.1056/NEJM197207062870105
Source DB: PubMed Journal: N Engl J Med ISSN: 0028-4793 Impact factor: 91.245